Literature DB >> 18502798

Mechanistic studies on ADAMTS13 catalysis.

Enrico Di Stasio1, Stefano Lancellotti, Flora Peyvandi, Roberta Palla, Pier Mannuccio Mannucci, Raimondo De Cristofaro.   

Abstract

The zinc-protease a disintegrin-like and metalloprotease with thrombospondin type I repeats (ADAMTS13) cleaves the Tyr(1605)-Met(1606) peptide bond of von Willebrand factor (VWF), avoiding the accumulation of ultra large VWF multimers. Hydrolysis by ADAMTS13 of a VWF analog (Asp(1596)-Arg(1668) peptide, fluorescence energy transfer substrate [FRETS]-VWF73) was investigated by a fluorescence quenching method (FRETS method) from 15 degrees C to 45 degrees C and pH values from 4.5 to 10.5. The catalysis was influenced by two ionizable groups, whose pK(a) values were equal to 6.41 +/- 0.08 (ionization enthalpy = 32.6 +/- 1.7 kJ/mol) and 4 +/- 0.1 (ionization enthalpy = 3.8 +/- 0.4 kJ/mol), whereas these values were equal to 6 +/- 0.1 and 4.1 +/- 0.1, respectively, in Co(2+)-substituted ADAMTS13. The catalytic process of FRETS-VWF73 hydrolysis showed negative activation entropy (-144 kJ/mol), suggesting that the transition state becomes more ordered than the ground state of the reactants. The k(cat)/K(m) values were not linearly correlated with temperature, as expression of change of the kinetic "stickiness" of the substrate. The Met(1606)-Arg(1668) peptide product acted as hyperbolic mixed-type inhibitor of FRETS-VWF73 hydrolysis. Asp(1653), Glu(1655), Glu(1660), Asp(1663), together with the hydrophilic side chain of Thr(1656) were shown to form a "hot spot" in the VWF A2 sequence, which drives the molecular recognition and allosteric regulation of binding to ADAMTS13. The interaction of the Met(1606)-Arg(1668) region of VWF with ADAMTS13 involves basic residues of the protease and is thus progressively inhibited at pH values >8.50. A molecular model of the FRETS-VWF73 showed that the substrate can fit into the active site only if ADAMTS13 assumes a C-like shape and, interacting with the acidic 1653-1668 region of VWF, properly orients the Tyr(1605)-Met(1606) peptide bond for the cleavage by the zinc-aquo complex in the active site.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502798      PMCID: PMC2517044          DOI: 10.1529/biophysj.108.131532

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  44 in total

1.  The PSIPRED protein structure prediction server.

Authors:  L J McGuffin; K Bryson; D T Jones
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

2.  A simple method for the determination of individual rate constants for substrate hydrolysis by serine proteases.

Authors:  Y M Ayala; E Di Cera
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

3.  pH- and temperature-dependence of functional modulation in metalloproteinases. A comparison between neutrophil collagenase and gelatinases A and B.

Authors:  G F Fasciglione; S Marini; S D'Alessio; V Politi; M Coletta
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

4.  Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains.

Authors:  Stefan Gerhardt; Giles Hassall; Paul Hawtin; Eileen McCall; Liz Flavell; Claire Minshull; David Hargreaves; Attilla Ting; Richard A Pauptit; Andrew E Parker; W Mark Abbott
Journal:  J Mol Biol       Date:  2007-08-02       Impact factor: 5.469

5.  Molecular mapping of the chloride-binding site in von Willebrand factor (VWF): energetics and conformational effects on the VWF/ADAMTS-13 interaction.

Authors:  Raimondo De Cristofaro; Flora Peyvandi; Luciano Baronciani; Roberta Palla; Silvia Lavoretano; Rossana Lombardi; Enrico Di Stasio; Augusto B Federici; Pier Mannuccio Mannucci
Journal:  J Biol Chem       Date:  2006-08-09       Impact factor: 5.157

6.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

7.  Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13.

Authors:  J Rayes; A Hommais; P Legendre; H Tout; A Veyradier; B Obert; A S Ribba; J P Girma
Journal:  J Thromb Haemost       Date:  2006-11-01       Impact factor: 5.824

8.  Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.

Authors:  Jing-Jiang Wu; Kazuo Fujikawa; Brad A McMullen; Dominic W Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-22       Impact factor: 11.205

9.  Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients.

Authors:  Bon-Hun Koo; Doyeun Oh; So Young Chung; Nam Keun Kim; Seonyang Park; Yangsoo Jang; Kwang-Hoe Chung
Journal:  Thromb Res       Date:  2002-03-15       Impact factor: 3.944

10.  Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress.

Authors:  Kyuhwan Shim; Patricia J Anderson; Elodee A Tuley; Erin Wiswall; J Evan Sadler
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

View more
  12 in total

1.  Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers.

Authors:  Svenja Lippok; Matthias Radtke; Tobias Obser; Lars Kleemeier; Reinhard Schneppenheim; Ulrich Budde; Roland R Netz; Joachim O Rädler
Journal:  Biophys J       Date:  2016-02-02       Impact factor: 4.033

2.  Allosteric activation of ADAMTS13 by von Willebrand factor.

Authors:  Joshua Muia; Jian Zhu; Garima Gupta; Sandra L Haberichter; Kenneth D Friedman; Hendrik B Feys; Louis Deforche; Karen Vanhoorelbeke; Lisa A Westfield; Robyn Roth; Niraj Harish Tolia; John E Heuser; J Evan Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

3.  ADAMTS13 and von Willebrand factor interactions.

Authors:  Catherine B Zander; Wenjing Cao; X Long Zheng
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

4.  Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13.

Authors:  L Deforche; E Roose; A Vandenbulcke; N Vandeputte; H B Feys; T A Springer; L Z Mi; J Muia; J E Sadler; K Soejima; H Rottensteiner; H Deckmyn; S F De Meyer; K Vanhoorelbeke
Journal:  J Thromb Haemost       Date:  2015-10-20       Impact factor: 5.824

Review 5.  ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura.

Authors:  Konstantine Halkidis; X Long Zheng
Journal:  J Thromb Haemost       Date:  2022-08-03       Impact factor: 16.036

6.  An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura.

Authors:  J Muia; W Gao; S L Haberichter; L Dolatshahi; J Zhu; L A Westfield; S C Covill; K D Friedman; J E Sadler
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

7.  Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study.

Authors:  Stefano Lancellotti; Maria Basso; Vito Veca; Monica Sacco; Laura Riccardi; Maurizio Pompili; Raimondo De Cristofaro
Journal:  Intern Emerg Med       Date:  2016-05-24       Impact factor: 3.397

8.  A human monoclonal antibody against the distal carboxyl terminus of ADAMTS-13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura.

Authors:  Konstantine Halkidis; Don L Siegel; X Long Zheng
Journal:  J Thromb Haemost       Date:  2021-05-11       Impact factor: 16.036

9.  Prediction of spacer-α6 complex: a novel insight into binding of ADAMTS13 with A2 domain of von Willebrand factor under forces.

Authors:  Xiang Fang; Jiangguo Lin; Ying Fang; Jianhua Wu
Journal:  Sci Rep       Date:  2018-04-10       Impact factor: 4.379

10.  AFM Imaging Reveals Multiple Conformational States of ADAMTS13.

Authors:  Shanshan Yu; Wang Liu; Jinhua Fang; Xiaozhong Shi; Jianhua Wu; Ying Fang; Jiangguo Lin
Journal:  J Biol Eng       Date:  2019-01-22       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.